摘要：

A method of modulating the activity of the GPR119 G protein-coupled receptor comprising administering to a mammalian patient in need thereof a therapeutically effective amount of at least one compound of Formula (I) or Formula (IA) and, optionally, an additional therapeutic agent.

展开